Philip D. Stein - Concepedia

Author

Philip D. Stein

Bristol-Myers Squibb (United States)

Also Known As

P D Stein, P Stein, P. D. STEIN, P. Stein, Philip D. Stein, Philip Stein

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Bristol-Myers Squibb (Germany)University of Pittsburgh Medicina Bristol-Myers Squibb (Sweden)

About

Philip D. Stein is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, drug discovery, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	21	891
2	Natural Sciences	15	16	898
3	Biochemistry	14	15	750
4	Engineering	4	4	262
5	Health Sciences	2	2	28

Philip D. Stein

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
(+)-SJ733, a clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance of <i>Plasmodium</i> Marı́a Belén Jiménez-Dı́az, Daniel Ebert, Yandira G. Salinas, Proceedings of the National Academy of Sciences Phenotypic ScreeningAntiparasitic AgentMalariaImmunologyMolecular Biology	2014	238
The Discovery of Sulfonamide Endothelin Antagonists and the Development of the Orally Active ETA Antagonist 5-(Dimethylamino)-N-(3,4-dimethyl-5- isoxazolyl)-1-naphthalenesulfonamide Philip D. Stein, John T. Hunt, David Floyd, Journal of Medicinal Chemistry Pharmaceutical ScienceAltmetric Attention ScorePharmacotherapy3,4-Dimethyl-5- IsoxazolylChemical Biology	1994	137
Selective blockade of the endothelin subtype A receptor decreases early atherosclerosis in hamsters fed cholesterol. Mark C. Kowala, Patricia M. Rose, Philip D. Stein, PubMed	1995	127
The INOC route to carbocyclics: a formal total synthesis of (.+-.)-sarkomycin Alan P. Kozikowski, Philip D. Stein Journal of the American Chemical Society Inoc RouteBioorganic ChemistryEngineeringAltmetric Attention ScoreOrganic Chemistry	1982	125
Intramolecular nitrile oxide cycloaddition route to carbocyclics: a formal total synthesis of PGF2.alpha. Alan P. Kozikowski, Philip D. Stein The Journal of Organic Chemistry Molecular SciencesEngineeringHeterocyclicMedicineAltmetric Attention Score	1984	77
Hit-to-Lead Studies for the Antimalarial Tetrahydroisoquinolone Carboxanilides David Floyd, Philip D. Stein, Zheng Wang, Journal of Medicinal Chemistry Medicinal ChemistryPhenotypic Whole-cell ScreeningBiochemistryAntiparasitic AgentMedicine	2016	55
BMS-182874 is a selective, nonpeptide endothelin ETA receptor antagonist. Marjorie Webb, J. Eileen Bird, Eddie C.‐K. Liu, Journal of Pharmacology and Experimental Therapeutics	1995	41
Biphenylsulfonamide Endothelin Antagonists: Structure−Activity Relationships of a Series of Mono- and Disubstituted Analogues and Pharmacology of the Orally Active Endothelin Antagonist 2‘-Amino-<i>N</i>- (3,4-dimethyl-5-isoxazolyl)-4‘-(2-methylpropyl)[1,1‘-biphenyl]-2-sulfonamide (BMS-187308) Natesan Murugesan, Zhengxiang Gu, Philip D. Stein, Journal of Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryPharmaceutical ScienceBiochemistryDisubstituted Analogues	1998	40
Biphenylsulfonamide Endothelin Receptor Antagonists. 2. Discovery of 4‘-Oxazolyl Biphenylsulfonamides as a New Class of Potent, Highly Selective ET<sub>A</sub> Antagonists Natesan Murugesan, Zhengxiang Gu, Philip D. Stein, Journal of Medicinal Chemistry Molecular PharmacologyMedicinal Chemistry‘ -Oxazolyl BiphenylsulfonamidesBiochemistryMedicine	2000	36
Discovery and Structure-Activity Relationships of Sulfonamide ETA-Selective Antagonists Philip D. Stein, David Floyd, Sharon N. Bisaha, Journal of Medicinal Chemistry	1995	36

Page 1